A strategic patentability search that revealed how dosage normalization and therapeutic context can uncover stronger pharmaceutical prior art.
The client sought a comprehensive patentability assessment for a pharmaceutical composition comprising bupropion and a phosphodiesterase-5 (PDE5) inhibitor intended for the treatment of female sexual dysfunction and delayed ejaculation.
The claimed invention defined both active ingredients within specific dosage ranges, with daily administration forming an important aspect of the therapeutic regimen.
This investigation required evaluating the novelty of an entire treatment framework involving:
Determine whether the claimed pharmaceutical composition, dosage ranges and therapeutic application satisfied the requirements for patentability.
The investigation initially followed a conventional pharmaceutical patent search methodology focused on identifying prior disclosures through established patent and scientific databases.
The initial searches successfully identified numerous references related to bupropion, PDE5 inhibitors, female sexual dysfunction, delayed ejaculation, smoking cessation and premature ejaculation. However, these references primarily disclosed isolated therapeutic concepts rather than the complete composition claimed in the invention.
Several relevant references were identified; however, none initially disclosed the complete therapeutic framework in a manner suitable for a confident patentability assessment.
These challenges demonstrated that relying solely on fixed dosage ranges and disease-specific terminology risked excluding technically relevant prior art.
Looking beyond the Conventional Keyword Search
One of the primary technical challenges involved locating prior art despite inconsistent dosage representations across patent and scientific literature.
Instead of restricting the search to fixed dosage values, equivalent dosage expressions and alternative reporting methods were systematically analyzed.
This broader approach enabled identification of references that would likely remain hidden through narrow keyword searching.
Another challenge involved differentiating references directed toward therapeutically related but legally distinct medical conditions.
The investigation categorized literature according to therapeutic indication, treatment objective, dosage strategy and composition.
This allowed the investigation to capture disclosures that described comparable dosage concepts using different scientific conventions.
The refined investigation successfully identified multiple highly relevant references supporting the patentability assessment.
This investigation illustrates that pharmaceutical patentability assessments often require more than conventional literature searches. By accounting for variations in:
The methodology provides a structured framework that can be applied to future composition-based patentability investigations involving complex formulations and therapeutic combinations.
This case study demonstrates that evaluating pharmaceutical composition patents requires a search strategy that extends beyond exact ingredient names and fixed dosage values.
Although traditional searches provide an essential starting point, meaningful patentability assessments often depend on recognizing equivalent dosage representations, related therapeutic indications and alternative descriptions of similar treatment regimens.
By systematically refining the investigation around dosage normalization, therapeutic context and composition-level analysis, the project identified highly relevant patent and non-patent literature that strengthened the overall patentability assessment.
More broadly, the investigation reinforces the importance of combining pharmaceutical domain expertise with structured prior art methodology when assessing complex composition patents, particularly where novelty depends on the interaction of multiple formulation variables rather than a single active ingredient.
Need Support for Complex Pharmaceutical Patent Investigations?
Our team specializes in pharmaceutical patentability analysis, prior art research and evidence-driven investigations for complex composition-based patent claims.
